Sanitar Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,614	2,601	2,770	2,481	2,652	2,358
Other Revenue	18.07	17.47	20.2	19.59	17.44	14.98
Revenue	2,632	2,618	2,790	2,501	2,670	2,373
Revenue Growth	-5.33%	-6.17%	11.58%	-6.32%	12.52%	2.87%
Cost of Revenue	1,630	1,654	1,801	1,643	1,750	1,575
Gross Profit	1,002	964.13	989.48	857.62	919.34	797.55
Selling, General & Admin	589.34	573	575.77	535.16	518.69	483.14
Research & Development	36.49	34.02	37.89	35.19	28.61	22.83
Other Operating Expenses	-	-	-	-	-	0.11
Operating Expenses	589.19	607.02	616.96	569.01	546.72	510.32
Operating Income	412.61	357.11	372.52	288.61	372.63	287.23
Interest Expense	-4.93	-5.09	-5.11	-5.88	-7.72	-7.07
Interest & Investment Income	18.59	15.44	10.67	7.56	4.35	3.73
Currency Exchange Gain (Loss)	7.84	7.84	15.53	8.86	9.82	3.97
Other Non Operating Income (Expenses)	56.07	0.8	0.89	2.9	1.47	2.11
EBT Excluding Unusual Items	490.18	376.1	394.51	302.04	380.54	289.97
Gain (Loss) on Sale of Investments	0.57	0.57	12.87	4.6	2.5	-3.18
Gain (Loss) on Sale of Assets	10.1	10.1	1.01	1.62	0.39	0.92
Asset Writedown	-32.45	-32.45	-	-	-	-
Other Unusual Items	-	-	0.17	-	-	-
Pretax Income	468.39	354.32	408.55	308.26	383.43	287.71
Income Tax Expense	100.5	90.84	87.44	70.8	88.14	62.86
Earnings From Continuing Operations	367.9	263.48	321.11	237.46	295.29	224.85
Minority Interest in Earnings	-3.05	-1.27	-5.88	-1.82	-4.46	-3.48
Net Income	364.85	262.21	315.23	235.64	290.83	221.37
Net Income to Common	364.85	262.21	315.23	235.64	290.83	221.37
Net Income Growth	30.68%	-16.82%	33.78%	-18.98%	31.38%	0.58%
Shares Outstanding (Basic)	73	73	72	72	72	72
Shares Outstanding (Diluted)	73	73	73	73	73	72
Shares Change	0.23%	0.48%	0.27%	-0.06%	0.35%	-0.43%
EPS (Basic)	5.02	3.61	4.37	3.27	4.04	3.07
EPS (Diluted)	4.99	3.59	4.33	3.25	4.01	3.06
EPS Growth	30.64%	-17.09%	33.23%	-18.95%	31.05%	0.99%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	296.73	423.98	252.18	303.25	334.37	216.22
Free Cash Flow Per Share	4.05	5.80	3.47	4.18	4.61	2.99
Dividend Per Share	2.200	2.200	2.400	1.800	2.300	2.000
Dividend Growth	-8.33%	-8.33%	33.33%	-21.74%	15.00%	0%
Gross Margin	38.06%	36.82%	35.46%	34.29%	34.44%	33.62%
Operating Margin	15.68%	13.64%	13.35%	11.54%	13.96%	12.11%
Profit Margin	13.86%	10.02%	11.30%	9.42%	10.89%	9.33%
Free Cash Flow Margin	11.27%	16.19%	9.04%	12.13%	12.53%	9.11%
EBITDA	483.7	430.03	455.6	375.22	462.99	375.72
EBITDA Margin	18.38%	16.42%	16.33%	15.00%	17.34%	15.84%
D&A For EBITDA	71.09	72.92	83.07	86.61	90.37	88.5
EBIT	412.61	357.11	372.52	288.61	372.63	287.23
EBIT Margin	15.68%	13.64%	13.35%	11.54%	13.96%	12.11%
Effective Tax Rate	21.46%	25.64%	21.40%	22.97%	22.99%	21.85%
Revenue as Reported	2,632	2,618	2,790	2,501	2,670	2,373